A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

No Carolina / New York

Mammography System Market Revenue to Cross USD 4B by 2027

February 18, 2021

The rising incidence of breast cancer coupled with continuous technological advancement in the field of mammography devices will foster market growth.

Major factors augmenting the burden of breast cancer are the increasing geriatric population, history of breast cancer, dense breast tissue, obesity, alcohol consumption, and radiation exposure. Innovation in mammography devices allows the early detection of breast cancers. The mammography machines produce exceptionally sharp images and seamless transition between imaging mode and advanced clinical application. Thus these features help in the early detection of breast cancer, thereby rendering it favorable for timely treatment protocol.

Request for a sample of this research report at https://www.gminsights.com/request-sample/detail/2637

The increasing number of product launches coupled with speedy product approval is positively impacting the mammography system market expansion. Introduction AI-based breast imaging technology is improving the clinical outcome and saving time. AI-based mammography devices can accurately and reliably classify breast tissues without any intervention. The introduction of such mammography devices has reduced the cost of treatment, owing to the reduction in false positive and abnormal interpretation. Thus, continuous technological advancements and the availability of advanced treatment options will create demand for mammography systems in foreseeable future.

Full field digital mammography (FFDM) dominated more than 66% of the market share in 2020 led by increasing adoption rate and significant improvement in clinical outcome. Moreover, these systems offer enhanced screening in young as well as dense breast tissue women. Thus, the superior benefits of full field digital mammography devices compared with other devices will boost the product demand.

Increasing use of 3D mammography devices in various applications of breast cancer is propelling the mammography system market value. The 3D mammography technology provides advanced images of breast tissues and characterization of breast lesions. Thus, availability of reimbursement to patients, low recall rates, and significant rise in detection of invasive cancer will fuel the segment growth during the forecast period.

The hospital segment is projected to reach over USD 2.5 billion by 2027. An increasing number of breast cancer cases globally will drive the number of mammography screenings in hospitals. The availability of high-end technology coupled with the presence of experienced radiologists also influences device usage. Furthermore, favorable reimbursement for mammography tests in hospitals and government initiatives will significantly contribute to the overall market revenue.

The Asia-Pacific mammography system market is expected to register a significant growth rate during the forecast period. The increasing incidence of cancer cases and the growing awareness about early diagnosis of cancer among young and adult women are driving the screening procedure demand in the region. In addition, growing healthcare expenditure, rising usage of novel technologies, and availability of mobile screening tools will further spur the market demand in the coming year.

Request for customization of this research report here.

Major players operating in the global mammography system market include Analogic Corporation, Hologic, Canon Medical System Corporation (Toshiba Medical System Corporation), Fujifilm Holding Corporation, GE healthcare, Hologic, and Siemens Healthineers. Established industry leaders are continuously involved in product development and adoption of novel technologies. These companies are focusing on the enhancement of distribution networks to boost the product reach and sales.

Table of Contents (ToC) of the report:

Chapter 3   Mammography System Market Insights

3.1    Industry segmentation

3.2    Industry landscape, 2016 – 2027 (USD Million)

3.3    Industry impact forces

3.3.1    Growth drivers

3.3.2    Industry pitfalls & challenges

3.4    Growth potential analysis

3.4.1    By product

3.4.2    By technology

3.4.3    By end-use

3.5    COVID-19 impact analysis

3.6    Regulatory landscape

3.7    Reimbursement landscape

3.8    Technology landscape

3.9    Pricing analysis

3.10    Porter’s analysis

3.11    Competitive landscape, 2020

3.12    PESTEL analysis

Browse Complete Table of Contents (ToC) at


About Global Market Insights, Inc.

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy, and biotechnology.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Dr. Sachita Shah, Sr. Director, Global Health, Butterfly Network, "Butterfly is proud to continue improving maternal health equity through Phase Two of the largest-scale handheld ultrasound distribution and training ever conducted in Sub-Saharan Africa. South Africa is an emerging market that continues to have disproportionately high rates of maternal mortality and stillbirth. Patients need easier access to antenatal imaging, and clinicians need better capabilities for screening high-risk conditions that lead to disproportionately worse pregnancy outcomes in rural areas in the public sector. Together with CHAI and GUSI, we can tackle this by making ultrasound much more accessible, so high-risk conditions can be identified earlier in care, which is known to improve outcomes.”
The clinical Study will enroll up to 97 patients at up to 12 European investigational sites. Completion of the study is expected this year, and results will support CE mark and pre-market approval submissions reports Vivasure Medical.
Dr. Michael Newman, Indaptus’ Founder, Chief Scientific Officer, and lead author, commented, “The new data are consistent with our preclinical animal tumor model studies and provide evidence for our hypothesis that patented Decoy bacteria can activate a wide range of innate and adaptive human immune cells involved in fighting tumors.  This aligns with what we’ve observed in our ongoing Phase 1 clinical trial of Decoy20 – broad immune activation, as evidenced by transiently increased levels of many key cytokines and chemokines following single dose administration. These findings bolster our confidence in Decoy20's potential as a multifaceted immunotherapy.”
To further understand the impact of platforms like TikTok on nutrition trends, MyFitnessPal partnered with Dublin City University on a research and experimental study that examined diet and nutrition content on TikTok. The study analyzed over 67,000 videos using Artificial Intelligence to compare them against public health and nutrition guidelines
Leveraging the power of Apple Vision Pro to seamlessly blend digital content with the physical world Osso Health brings the operating experience to life via detailed, clinically accurate workflows of common procedures.

By using this website you agree to accept Medical Device News Magazine Privacy Policy